Nav: Home

Rabies vaccine effective even after warm storage

October 24, 2016

PULLMAN, Wash. - A Washington State University-led research team determined rabies vaccines stored at warmer temperatures still protect against the disease in dogs.

The work, published in the journal Vaccine, could lead to improved vaccination coverage in hard to reach, rural areas in Africa and Asia where electricity for cooling is limited.

"Thermotolerant vaccines were a really important feature of the campaign to eliminate smallpox," said Felix Lankester, lead author and clinical assistant professor in the WSU Paul G. Allen School for Global Animal Health. "We hope it will have the same effect for eradicating rabies."

Recommendations by the World Health Organization are for vaccines to be transported and stored in a "cold chain" at between 2°C (35.6°F) and 8°C (46.4°F). Lankester and his colleagues found that Nobivac, a commonly used rabies vaccine, produces the same level of protective antibodies in dogs after being stored for six months at 25°C (77°F) and for three months at 30°C (86°F).

"The ability to distribute vaccines widely outside the cold chain will allow for more consistent coverage across communities," said Lankester. "It could be a quantum shift in how vaccines are delivered."

Eradicating one of the deadliest diseases

"Human rabies from dog bites has the highest fatality rate of any human infectious disease," said Guy Palmer, WSU's senior director of global health. "But rabies is easily preventable with regular dog vaccinations.

felix-administering-vaccine-2015-web

Felix Lankester, left, WSU clinical assistant professor, takes a blood sample to test whether a rabies vaccine stored at warmer temperatures is effective against the disease.

Each year roughly 60,000 people, mostly children, die from rabies. Globally, more than 99 percent of human rabies deaths are caused by dog bites -- almost all in sub-Saharan Africa and Asia.

Millions of people are saved by costly post-exposure prophylaxis - a series of post-bite vaccinations, the first of which must be administered within the first 24 hours after a person is bitten by a rabid dog. But once symptoms appear, the disease is fatal.

Vaccinating 70 percent of the dog population will protect humans and wildlife, such as endangered African wild dogs, from the disease.

WSU, in collaboration with the Serengeti Health Initiative, has been working to control rabies in areas of northern Tanzania through annual mass dog rabies vaccination campaigns. But rabies continues to be prevalent, in part because of the challenges of transporting vaccines to remote areas where vulnerable people live in resource-poor communities.

"If a team-led vaccination campaign misses a village because it is very far or because rain washed out a bridge, then there will be pockets where vaccination coverage is low," said Lankester. "With a community-led initiative, we are hopeful we would improve the coverage levels."

Empowering communities to lead vaccination programs

Mass vaccination teams generally only visit communities once a year, if they can get there at all. When new dogs are born or move into the community, the level of protection against rabies drops. In community-led programs, thermotolerant vaccines could be stored in the community where local coordinators would vaccinate the entire dog population.

"Through community-led programs, coverage could be kept relativity consistently high, which would reduce the likelihood of rabies returning to a community," said Lankester. "These findings also give confidence to those working to control rabies that if vaccines are kept outside of the cold chain for a small time, they don't have to be thrown away."

In the next phase of the research, Lankester and his colleagues will test the effectiveness of using low-tech cooling options for storing rabies vaccines in rural communities.
-end-


Washington State University

Related Vaccines Articles:

Understanding T cell activation could lead to new vaccines
Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.
Vaccines do work for pandemic flu, says study
Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalized as a result of the illness, a study led by academics at the University of Nottingham has found.
Research could lead to better vaccines and new antivirals
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new regulator of the innate immune response -- the immediate, natural immune response to foreign invaders.
Toward opioid vaccines that can help prevent overdose fatalities
In 2014, the number of deaths from opioid overdoses in the US jumped to its highest level on record.
New, more effective strategy for producing flu vaccines
A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines that protect people from influenza B.
A method for storing vaccines at room temperature
Several simple and inexpensive techniques make it possible to store antiviral-vaccines at room temperature for several months.
Engineers design programmable RNA vaccines
MIT engineers have designed programmable RNA vaccines that could be rapidly manufactured and deployed.
Zika vaccines protect mice from infection
A single dose of either of two experimental Zika vaccines fully protected mice challenged with Zika virus four or eight weeks after receiving the inoculations.
Can we hypercharge vaccines?
Researchers at Boston Children's Hospital report that a fatty chemical naturally found in damaged tissues can induce an unexpected kind of immune response, causing immune cells to go into a 'hyperactive' state that is highly effective at rallying infection-fighting T-cells.
Vaccines: Don't leave home without them
While Americans should be fully vaccinated before travelling internationally to avoid infection with highly contagious diseases such as measles and hepatitis A, many are not, suggest two studies being presented at IDWeek 2015™.

Related Vaccines Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#514 Arctic Energy (Rebroadcast)
This week we're looking at how alternative energy works in the arctic. We speak to Louie Azzolini and Linda Todd from the Arctic Energy Alliance, a non-profit helping communities reduce their energy usage and transition to more affordable and sustainable forms of energy. And the lessons they're learning along the way can help those of us further south.